Stay updated on Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial
Sign up to get notified when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.

Latest updates to the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s revision/version indicator is updated from v3.5.0 to v3.5.3, reflecting a site/UI or publishing software update rather than a change to the clinical trial information.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This indicates a new software version with no visible impact on study content.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision note updated to include Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page shows Revision: v3.4.2 replacing v3.4.1, indicating a minor maintenance update that does not alter study information.SummaryDifference0.1%

- Check97 days agoChange DetectedThe revision label on the page was updated from v3.4.0 to v3.4.1, with no changes to the study details or other substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check104 days agoChange DetectedThe page now includes a glossary toggle, a 'Last Update Submitted that Met QC Criteria' line, a 'No FEAR Act Data' notice, and Revision: v3.4.0. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed.SummaryDifference0.2%

Stay in the know with updates to Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.